Pictet Asset Management (Switzerland)’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $3.71M | Buy |
54,998
+11,447
| +26% | +$773K | ﹤0.01% | 822 |
|
2023
Q1 | $20.3M | Buy |
43,551
+23,757
| +120% | +$11.1M | 0.03% | 453 |
|
2022
Q4 | $7.93M | Buy |
19,794
+5,225
| +36% | +$2.09M | 0.01% | 640 |
|
2022
Q3 | $4.74M | Buy |
14,569
+2,180
| +18% | +$709K | 0.01% | 741 |
|
2022
Q2 | $3.27M | Buy |
12,389
+3,963
| +47% | +$1.05M | ﹤0.01% | 843 |
|
2022
Q1 | $2.53M | Hold |
8,426
| – | – | ﹤0.01% | 928 |
|
2021
Q4 | $2.97M | Buy |
8,426
+4,434
| +111% | +$1.56M | ﹤0.01% | 931 |
|
2021
Q3 | $1.02M | Buy |
+3,992
| New | +$1.02M | ﹤0.01% | 1069 |
|